Mutations in the pantothenate kinase gene PANK2 are not associated with Parkinson disease

Neuroscience Letters

Volumn 379, Issue 3, 2005, Pages 195-198

  Klopstock, Thomas ^a   Elstner, Matthias ^a   Lücking, Christoph B ^a   Müller Myhsok, Bertram ^b   Gasser, Thomas ^c   Botz, Evelyn ^d   Lichtner, Peter ^d   Hörtnagel, Konstanze ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Pantothenate kinase associated neurodegeneration; Parkinson disease

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE; GENE MUTATION; GENETIC ANALYSIS; GENETIC RISK; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; ONSET AGE; PANTOTHENATE KINASE 2 GENE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 17444374981     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.12.061     Document Type: Article

References (17)

1. R. Alberca, E. Rafel, I. Chinchon, J. Vadillo, and A. Navarro Late onset parkinsonian syndrome in Hallervorden-Spatz disease J. Neurol. Neurosurg. Psychiatry 50 1987 1665 1668
2. P.D. Griffiths, B.R. Dobson, G.R. Jones, and D.T. Clarke Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy Brain 122 1999 667 673
3. K. Hedrich, A. Djarmati, N. Schafer, R. Hering, C. Wellenbrock, P.H. Weiss, R. Hilker, P. Vieregge, L.J. Ozelius, P. Heutink, V. Bonifati, E. Schwinger, A.E. Lang, J. Noth, S.B. Bressman, P.P. Pramstaller, O. Riess, and C. Klein DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease Neurology 62 2004 389 394
4. J. Jankovic, J.B. Kirkpatrick, K.A. Blomquist, P.J. Langlais, and E.D. Bird Late-onset Hallervorden-Spatz disease presenting as familial parkinsonism Neurology 35 1985 227 234
5. K. Jellinger, and E. Neumayer Unusual late-onset type of Hallervorden-Spatz disease. Clinico-pathological study of a case presenting as parkinsonism Z. Neurol. 203 1972 105 118
6. S.J. Lincoln, D.M. Maraganore, T.G. Lesnick, R. Bounds, M. de Andrade, J.H. Bower, J.A. Hardy, and M.J. Farrer Parkin variants in North American Parkinson's disease: cases and controls Mov. Disord. 18 2003 1306 1311
7. C.B. Lücking, A. Dürr, V. Bonifati, J. Vaughan, G. De Michele, T. Gasser, B.S. Harhangi, G. Meco, P. Denefle, N.W. Wood, Y. Agid, and A. Brice Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group N. Engl. J. Med. 342 2000 1560 1567
8. M. Neumann, S. Adler, O. Schlüter, E. Kremmer, R. Benecke, and H.A. Kretzschmar Alpha-synuclein accumulation in a case of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type Lewy bodies Acta Neuropathol. 100 2000 568 574
9. E.H. Norris, B.I. Giasson, and V.M. Lee Alpha-synuclein: normal function and role in neurodegenerative diseases Curr. Top. Dev. Biol. 60 2004 17 54
10. B.A. Racette, A. Perry, G. D'Avossa, and J.S. Perlmutter Late-onset neurodegeneration with brain iron accumulation type 1: expanding the clinical spectrum Mov. Disord. 16 2001 1148 1152
11. Y. Saito, M. Kawai, and K. Inoue Widespread expression of alpha-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course J. Neurol. Sci. 177 2000 48 59
12. T.D. Taylor, M. Litt, P. Kramer, M. Pandolfo, L. Angelini, N. Nardocci, S. Davis, M. Pineda, H. Hattori, P.J. Flett, M.R. Cilio, E. Bertini, and S.J. Hayflick Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3 Nat. Genet. 14 1996 479 481
13. M. Thomas, S.J. Hayflick, and J. Jankovic Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration Mov. Disord. 19 2004 36 42
14. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert, Z. Ali, D. Del Turco, A.R. Bentivoglio, D.G. Healy, A. Albanese, R. Nussbaum, R. Gonzalez-Maldonado, T. Deller, S. Salvi, P. Cortelli, W.P. Gilks, D.S. Latchman, R.J. Harvey, B. Dallapiccola, G. Auburger, and N.W. Wood Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
15. K. Wakabayashi, T. Fukushima, R. Koide, Y. Horikawa, M. Hasegawa, Y. Watanabe, T. Noda, I. Eguchi, T. Morita, M. Yoshimoto, T. Iwatsubo, and H. Takahashi Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology Acta Neuropathol. 99 2000 331 336
16. A. West, M. Periquet, S. Lincoln, C.B. Lücking, D. Nicholl, V. Bonifati, N. Rawal, T. Gasser, E. Lohmann, J.F. Deleuze, D. Maraganore, A. Levey, N. Wood, A. Dürr, J. Hardy, A. Brice, M. Farrer French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility on Parkinson's Disease Complex relationship between Parkin mutations and Parkinson disease Am. J. Med. Genet. 114 2002 584 591
17. B. Zhou, S.K. Westaway, B. Levinson, M.A. Johnson, J. Gitschier, and S.J. Hayflick A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome Nat. Genet. 28 2001 345 349